Corient Private Wealth’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
46,474
+3,859
+9% +$35.4K ﹤0.01% 2358
2026
Q1
$396K Buy
42,615
+1,820
+4% +$17.9K ﹤0.01% 2154
2025
Q4
$285K Sell
40,795
-726
-2% -$4.57K ﹤0.01% 2204
2025
Q3
$237K Sell
41,521
-5,656
-12% -$30.2K ﹤0.01% 2269
2025
Q2
$226K Buy
47,177
+26,643
+130% +$153K ﹤0.01% 2164
2025
Q1
$178K Sell
20,534
-4,162
-17% -$43.6K ﹤0.01% 2102
2024
Q4
$300K Sell
24,696
-25,307
-51% -$354K ﹤0.01% 1896
2024
Q3
$841K Sell
50,003
-34,501
-41% -$568K ﹤0.01% 1488
2024
Q2
$1.32M Sell
84,504
-13,708
-14% -$191K ﹤0.01% 1216
2024
Q1
$1.55M Buy
98,212
+225
+0.2% +$3.77K ﹤0.01% 1156
2023
Q4
$1.97M Buy
97,987
+32,339
+49% +$547K ﹤0.01% 1007
2023
Q3
$1.22M Sell
65,648
-1,799
-3% -$39.2K ﹤0.01% 1124
2023
Q2
$1.47M Sell
67,447
-398
-0.6% -$7.2K ﹤0.01% 1012
2023
Q1
$1.26M Buy
67,845
+25,473
+60% +$479K ﹤0.01% 1005
2022
Q4
$645K Buy
+42,372
New +$603K ﹤0.01% 1060

Other funds holding NEOG

Corient Private Wealth's NEOG Position: Q2 2026 in Review

Corient Private Wealth increased its Neogen (NEOG) stake by 9.1% in Q2 2026, buying an estimated $35.4K and bringing the position to 46,474 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Corient Private Wealth first reported a position in NEOG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.97M in Q4 2023. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Corient Private Wealth held 46,474 shares of Neogen worth $418K as of Q2 2026.
  • Corient Private Wealth bought 3,859 Neogen shares in Q2 2026, an estimated $35.4K.
  • Neogen made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2358 holding.
  • Corient Private Wealth first reported a position in Neogen in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Neogen position peaked at $1.97M in Q4 2023.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.